
mmtul
4.5K posts

mmtul
@mmtul
Make more than you lose. MBA, CFA, CPA, over 30 years institut'l money mgmt. exper. as analyst, PM, HF Founder. Also former public biotech CFO.





Looks like $UNF shareholders are finally getting somewhere. The silence and lack of activity in the stock has been encouraging up to this point, but still has tested patience!

In 2022, $UNF could attempt a few weak arguments to substantiate their opposition to a sale. Now they can't. The enormous underperformance vs. the S&P and $CTAS is too great for anyone to defend for $UNF, so no one can make the argument to go it alone with a straight face IMO. And even if $CTAS can't get the deal across the goal line, what's wrong with the $UNF getting 10% of its market cap in cash for the exercise. Hard to argue that $275 is not a win, and they might be able to get more. If they don't take it, there seems to be a very good chance IMO of them presiding over a market share losing, declining value situation for many years to come. There would be nothing rational about declining this offer IMO, and employees would likely be better taken care of with a combination of generous severance and a much more competitive future than the bleak, share losing future that appears to be in store if $UNF goes it alone.


















